Molecure S.A. (WSE:MOC)
Poland · Delayed Price · Currency is PLN 5.95
+0.06 (1.02%)
Jul 24, 2026, 5:00 PM CET
Molecure Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6.52 | 2.93 | 3.67 | 7.54 | 1.46 | |
Revenue Growth (YoY) | 122.20% | -20.10% | -51.29% | 416.21% | -98.83% |
Cost of Revenue | 1.78 | 3.41 | 4.1 | 4.53 | 0.18 |
Gross Profit | 4.74 | -0.47 | -0.43 | 3.01 | 1.28 |
Selling, General & Admin | 17.57 | 23.02 | 26.88 | 34.39 | 8.99 |
Depreciation & Amortization Expenses | 3.01 | 3.82 | 3.88 | 3.98 | 0.3 |
Other Operating Expenses | 0.72 | 4.99 | 0.94 | 2.3 | 5.75 |
Total Operating Expenses | 21.3 | 31.83 | 31.7 | 40.68 | 15.04 |
Operating Income | -16.56 | -32.3 | -32.13 | -37.67 | -13.76 |
Interest Income | 1 | 1.13 | 4.39 | 1.91 | 0.79 |
Interest Expense | -0.13 | -0.11 | -0.63 | -0.19 | -0.66 |
Total Non-Operating Income (Expense) | 0.87 | 1.01 | 3.75 | 1.72 | 0.13 |
Pretax Income | -15.69 | -31.29 | -28.37 | -35.95 | -13.64 |
Net Income | -15.69 | -31.29 | -28.37 | -35.95 | -13.64 |
Net Income to Common | -15.69 | -31.29 | -28.37 | -35.95 | -13.64 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 20 | 20 | 17 | 14 | 14 |
Shares Outstanding (Diluted) | 20 | 20 | 17 | 14 | 14 |
Shares Change (YoY) | 1.26% | 20.00% | 20.00% | 0.53% | 0.69% |
EPS (Basic) | -0.76 | -1.55 | -1.69 | -2.56 | -0.98 |
EPS (Diluted) | -0.76 | -1.55 | -1.69 | -2.56 | -0.98 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -20.29 | -57.65 | -23.65 | -37.45 | -15.95 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.99 | -2.85 | -1.40 | -2.67 | -1.14 |
Gross Margin | 72.67% | -16.19% | -11.70% | 39.91% | 87.39% |
Operating Margin | -253.98% | -1100.95% | -874.90% | -499.71% | -942.54% |
Profit Margin | -240.64% | -1066.38% | -772.65% | -476.90% | -933.77% |
FCF Margin | -311.19% | -1964.72% | -644.09% | -496.77% | -1092.14% |
EBITDA | -15.58 | -28.48 | -29.3 | -33.69 | -13.46 |
EBITDA Margin | -239.04% | -970.76% | -797.94% | -446.86% | -922.01% |
EBIT | -16.56 | -32.3 | -32.13 | -37.67 | -13.76 |
EBIT Margin | -253.98% | -1100.95% | -874.90% | -499.71% | -942.54% |